@forbes.com 2 years ago Moderna: Don’t Be Greedy, Don’t Be Evil
@WSJ 4 years ago Executives and directors at Pfizer, Moderna and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping the rewards of positive vaccine developments on.wsj.com
@qz.com 4 years ago What’s going to happen to all those other Covid-19 vaccine candidates?
@WSJ 3 years ago Vaccine makers Pfizer and Moderna have both named company outsiders as chief financial officers as the companies look to deploy some of the cash they generated during the Covid-19 pandemic on.wsj.com
@WSJ 4 years ago Executives and directors at Pfizer, Moderna and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping the rewards of positive vaccine developments on.wsj.com
@forbes.com 4 years ago Moderna, Novavax, Pfizer: How Are Coronavirus Vaccine Stocks Faring?
@truthout.org 4 years ago Pfizer and Moderna Hike EU Vaccine Prices as Rich Countries Oppose Patent Waiver
@forbes.com 4 years ago Superyacht Service Expands Down Under
@forbes.com 4 years ago Vaccine Watch: Investors Await Pfizer, Moderna Results, Monitor Gilead Treatment
@forbes.com 4 years ago How The Covid-19 Vaccine Injected Billions Into Big Pharma—And Made Its Executives Very Rich
@cbsnews.com 4 years ago White House hosts summit on COVID vaccines without companies that produced shots